𝔖 Scriptorium
✦   LIBER   ✦

πŸ“

Statistical Methods in Health Disparity Research (Chapman & Hall/CRC Biostatistics Series)

✍ Scribed by J. Sunil Rao


Publisher
Chapman and Hall/CRC
Year
2023
Tongue
English
Leaves
298
Edition
1
Category
Library

⬇  Acquire This Volume

No coin nor oath required. For personal study only.

✦ Synopsis


A health disparity refers to a higher burden of illness, injury, disability, or mortality experienced by one group relative to others attributable to multiple factors including socioeconomic status, environmental factors, insufficient access to health care, individual risk factors, and behaviors and inequalities in education. These disparities may be due to many factors including age, income, and race. Statistical Methods in Health Disparity Research will focus on their estimation, ranging from classical approaches including the quantification of a disparity, to more formal modeling, to modern approaches involving more flexible computational approaches.

Features:

  • Presents an overview of methods and applications of health disparity estimation
  • First book to synthesize research in this field in a unified statistical framework
  • Covers classical approaches, and builds to more modern computational techniques
  • Includes many worked examples and case studies using real data
  • Discusses available software for estimation

The book is designed primarily for researchers and graduate students in biostatistics, data science, and computer science. It will also be useful to many quantitative modelers in genetics, biology, sociology, and epidemiology.

✦ Table of Contents


Cover
Half Title
Series Page
Title Page
Copyright Page
Dedication
Contents
Foreword
Preface
1. Basic Concepts
1.1. What is a health disparity?
1.2. A brief historical perspective
1.3. Some examples
1.4. Determinants of health
1.4.1. Biology and genetics
1.4.2. Individual behavior
1.4.3. Health services
1.4.4. Social determinants of health
1.4.5. (Health) policies
1.5. The challenging issue of race
1.5.1. Racial segregation as a social determinant of health
1.5.2. Racism, segregation, and inequality
1.6. Role of data visualization in health disparities research
1.7. A note on notation adopted in this book
2. Overall Estimation of Health Disparities
2.1. Data and measurement
2.2. Disparity indices
2.2.1. Total disparity indices
2.2.2. Disparity indices measuring differences between groups
2.2.3. Disparity indices from complex surveys
2.3. Randomized experiments: an idealized estimate of disparity
2.4. Model-based estimation: adjusting for confounders
2.4.1. Regression approach
2.4.1.1. Model-assisted survey regression
2.4.2. Peters-Belson approach
2.4.2.1. Peters-Belson approach for complex survey data
2.4.2.2. Peters-Belson approach for clustered data
2.4.3. Disparity drivers
2.4.3.1. Disparity drivers for complex survey data
2.5. Matching and propensity scoring
2.6. Discrete outcomes
2.6.1. Binary outcomes
2.6.2. Nominal and ordinal outcomes
2.6.3. Poisson regression and log-linear models
2.7. Survival analysis
2.7.1. Survivor and hazard functions
2.7.2. Common parametric models
2.7.3. Estimation
2.7.4. Inference
2.7.5. Non-parametric estimation of S(y)
2.7.6. Cox proportional hazards model
2.8. Multi-level modeling
2.8.1. Estimation and inference
2.9. Generalized estimating equations
2.9.1. Pseudo GEE for complex survey data
2.10. Bayesian methods
2.10.1. Intuitive motivation and practical advantages to Bayesian analyses
2.10.2. An overview of Bayesian inference
2.10.3. Markov Chain Monte Carlo (MCMC)
3. Domain-Specific Estimates
3.1. What is a domain?
3.2. Direct estimates
3.3. Indirect estimates
3.4. Small area model-based estimates
3.4.1. Small area estimation models
3.4.2. Estimation
3.4.3. Inference
3.5. Bayesian approaches
3.6. Observed best prediction (OBP)
3.6.0.1. OBP versus the BLUP
3.6.1. Nonparametric/semi-parametric small area estimation
3.6.2. Model selection and diagnostics
3.6.2.1. A simplified adaptive fence procedure
4. Causality, Moderation, and Mediation
4.1. Socioecological framework for health disparities
4.2. Causal inference in health disparities
4.2.1. Experimental versus observational studies
4.2.2. Challenges with certain variables to be treated causal factors
4.3. Average treatment effects
4.3.1. What are we trying to estimate and are these identifiable?
4.3.2. Estimation of ATE and related quantities
4.3.2.1. Regression estimators
4.3.2.2. Matching estimators
4.3.2.3. Propensity score methods
4.3.2.4. Combination methods
4.3.2.5. Bayesian methods
4.3.2.6. Uncertainty estimation for ATE estimators
4.3.3. Assessing the assumptions
4.4. Use of instrumental variables
4.4.1. Verifying the assumptions
4.4.2. Estimation
4.5. Traditional mediation versus causal mediation
4.5.1. Effect identification
4.6. Mediation analysis for health disparities
4.7. Traditional moderation versus causal moderation
4.7.1. Parallel estimation framework
4.7.2. Causal moderation without randomized treatments
5. Machine Learning Based Approaches to Disparity Estimation
5.1. What is machine learning (ML)?
5.1.1. Supervised versus unsupervised machine learning
5.1.2. Why is ML relevant for health disparity research?
5.2. Tree-based models
5.2.0.1. Understanding the decision boundary
5.2.0.2. Bagging trees
5.2.1. Tree-based models for health disparity research
5.3. Tree-based models for complex survey data
5.4. Random forests
5.4.1. Hypothesis testing for feature significance
5.5. Shrinkage estimation
5.5.1. Generalized Ridge Regression (GRR)
5.5.1.1. Geometrical and theoretical properties of the GRR estimator in high dimensions
5.5.2. Ideal variable selection for GRR
5.5.3. Spike and slab regression
5.5.3.1. Selective shrinkage and the oracle property
5.5.4. The elastic net (enet) and lasso
5.5.5. Model-assisted lasso for complex survey data
5.6. Deep learning
5.6.1. Deep architectures
5.6.2. Forward and backpropagation to train the ANN
5.7. Proofs
6. Health Disparity Estimation under a Precision Medicine Paradigm
6.1. What is precision medicine?
6.1.1. The role of genomic data
6.2. Disparity subtype identification using tree-based methods
6.2.1. PRISM approximation
6.2.2. Level set estimation (LSE) for disparity subtypes
6.3. Classified mixed model prediction
6.3.1. Prediction of mixed effects associated with new observations
6.3.2. CMMP without matching assumption
6.3.3. Prediction of responses of future observations
6.3.4. Some simulations
6.4. Assessing the uncertainty in classified mixed model predictions
6.4.1. Overview of Sumca
6.4.2. Implementation of Sumca to CMMP
6.4.3. A simulation study of Sumca
6.5. Proofs
7. Extended topics
7.1. Correcting for sampling bias in disease surveillance studies
7.1.1. The model
7.1.2. Bias correction
7.1.2.1. Large values of s
7.1.2.2. Small values of s
7.1.2.3. Prevalence
7.1.2.4. Middle values of s
7.1.2.5. M = 2
7.1.3. Estimated variance
7.2. Geocoding
7.2.1. The Public Health Geocoding Project
7.2.2. Geocoding considerations
7.2.3. Pseudo-Bayesian classified mixed model prediction for imputing area-level covariates
7.2.3.1. Consistency and asymptotic optimality of MPPM
7.3. Differential privacy and the impact on health disparities research
7.3.1. Multilevel modeling, mixed model prediction, and incorporating DP errors
7.4. R software for health disparity research
7.4.1. Typical R software development and testing/debugging workflow
7.4.2. The need for a health disparity R research repository
7.4.3. R packages relevant to Chapter 3
7.4.4. R packages relevant to Chapter 4
7.4.5. R packages relevant to Chapter 5
7.4.6. R packages relevant to Chapter 6
7.4.7. R packages relevant to Chapter 7
Bibliography
Index


πŸ“œ SIMILAR VOLUMES


Statistics in Drug Research: Methodologi
✍ Shein-Chung Chow, Jun Shao πŸ“‚ Library πŸ“… 2002 πŸ› CRC Press 🌐 English

Emphasizing the role of good statistical practices (GSP) in drug research and formulation, this book outlines important statistics applications for each stage of pharmaceutical development to ensure the valid design, analysis, and assessment of drug products under investigation and establish the saf

Multiple Testing Problems in Pharmaceuti
✍ Alex Dmitrienko, Ajit C. Tamhane, Frank Bretz πŸ“‚ Library πŸ“… 2009 πŸ› Chapman and Hall/CRC 🌐 English

Useful Statistical Approaches for Addressing Multiplicity IssuesIncludes practical examples from recent trials Bringing together leading statisticians, scientists, and clinicians from the pharmaceutical industry, academia, and regulatory agencies, Multiple Testing Problems in Pharmaceutical Statis

Controversial Statistical Issues in Clin
✍ Shein-Chung Chow πŸ“‚ Library πŸ“… 2011 πŸ› Chapman and Hall/CRC 🌐 English

In clinical trial practice, controversial statistical issues inevitably occur regardless of the compliance with good statistical practice and good clinical practice. But by identifying the causes of the issues and correcting them, the study objectives of clinical trials can be better achieved. Contr

Medical Statistics for Cancer Studies (C
✍ Trevor F. Cox πŸ“‚ Library πŸ“… 2022 πŸ› Chapman and Hall/CRC 🌐 English

<p><span>Cancer is a dreaded disease. One in two people will be diagnosed with cancer within their lifetime. </span><span>Medical Statistics for Cancer Studies</span><span> shows how cancer data can be analysed in a variety of ways, covering cancer clinical trial data, epidemiological data, biologic

Meta-Analysis in Medicine and Health Pol
✍ Donald A. Berry, Dalene K. Stangl πŸ“‚ Library πŸ“… 2000 πŸ› CRC Press 🌐 English

This remarkable text raises the analysis of data in health sciences and policy to new heights of refinement and applicability by introducing cutting-edge meta-analysis strategies while reviewing more commonly used techniques. Each chapter builds on sound principles, develops methodologies to solve s

Bayesian Adaptive Methods for Clinical T
✍ Scott M. Berry, Bradley P. Carlin, J. Jack Lee, Peter Muller πŸ“‚ Library πŸ“… 2010 πŸ› CRC Press 🌐 English

Already popular in the analysis of medical device trials, adaptive Bayesian designs are increasingly being used in drug development for a wide variety of diseases and conditions, from Alzheimer’s disease and multiple sclerosis to obesity, diabetes, hepatitis C, and HIV. Written by leading pioneers o